References
- Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic Ovary Syndrome, A Dunaif, JR Givens, FP Haseltine, et al. Blackwell Scientific, Oxford 1992; 337–84
- Guzick D. Polycystic ovary syndrome: symptomatology, pathophysiology and epidemiology. Am J Obstet Gynecol 1998; 179: S89–93
- Holte J, Berg T, Gennarelli G, et al. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 1994; 41: 473–81
- Poretsky L, Piper B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 1994; 84: 613–21
- Poison DW, Franks S, Reed MJ, et al. The distribution of oestradiol in plasma in relation to uterine cross-sectional area in women with polycystic or multifollicular ovaries. Clin Endocrinol 1987; 26: 581–8
- Gandar R, Spizzo M, Collin D. Diagnosis and treatment of polycystic ovary syndrome. J Gynecol Obstet Biol Reprod 1999; 28: 510–8
- Dunaif A. Insulin resistance and ovarian dysfunction. Insulin resistance, D Moller. Wiley and Sons, Boston 1993; 301–25
- Sinagra D, Scarpitta AM, Brigandi M, et al. Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity. Eur Rev Med Pharmacol Sci 1997; 1: 167–71
- Nesder JE, Powers LP, Matt DW. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991; 72: 83–9
- Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–74
- Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991; 12: 3–13
- Seino S, Seino M, Bell GI. Human insulin-receptor gene. Diabetes 1990; 39: 129–33
- Julier C, Weil D, Couillin P, et al. The beta chorionic gonadotropin-beta luteinizing gene cluster maps to human chromosome 19. Hum Genet 1984; 67: 174–7
- Dunaif A, Segal K, Shelley D, et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992; 41: 1257–66
- Ciaraldi T, El-Roeiy A, Madar Z, et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992; 75: 557–83
- Dunaif A, Green G, Finegood D. Pancreatic beta cell function is normal in insulin resistant women with the polycystic ovary syndrome (PCOS). 74th Annual Meeting of the Endocrine Society, San Antonio, 1992, abs. 280
- Sinagra D, Greco D, Scarpitta AM, et al. Feedback inhibition of insulin secretion in obese female subjects with different insulin-resistant states. Diab Nutr Metab 1997; 10: 185–8
- Ehrmann DA, Sturis J, Byrne MM, et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus. J Clin Invest 1995; 96: 520–7
- Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol 2000; 52: 181–6
- Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141–6
- Wild RA. Metabolic aspects of polycystic ovary syndrome. Semin Reprod Endocrinol 1997; 15: 105–10
- Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metabol Clin North Am 1999; 28: 247–63
- Panidis D, Skiadopoulos S, Rousso D, et al. Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome. Br J Dermatol 1994; 132: 936–41
- Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876–80
- Legro RS. Insulin resistance in polycystic ovary syndrome: treating a phenotype without a genotype. Mol Cell Endocrinol 1998; 145: 103–10